GB9602903D0 - Conjugates useful in the treatment of benign prostatic hyperplasia - Google Patents

Conjugates useful in the treatment of benign prostatic hyperplasia

Info

Publication number
GB9602903D0
GB9602903D0 GBGB9602903.8A GB9602903A GB9602903D0 GB 9602903 D0 GB9602903 D0 GB 9602903D0 GB 9602903 A GB9602903 A GB 9602903A GB 9602903 D0 GB9602903 D0 GB 9602903D0
Authority
GB
United Kingdom
Prior art keywords
treatment
benign prostatic
prostatic hyperplasia
conjugates useful
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9602903.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GBGB9602903.8A priority Critical patent/GB9602903D0/en
Publication of GB9602903D0 publication Critical patent/GB9602903D0/en
Priority to PCT/US1996/016490 priority patent/WO1997014416A1/en
Priority to EP96936504A priority patent/EP0855910A4/en
Priority to AU74321/96A priority patent/AU708475B2/en
Priority to JP9515930A priority patent/JP2000506494A/en
Priority to CA 2234763 priority patent/CA2234763A1/en
Pending legal-status Critical Current

Links

GBGB9602903.8A 1995-10-18 1996-02-13 Conjugates useful in the treatment of benign prostatic hyperplasia Pending GB9602903D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9602903.8A GB9602903D0 (en) 1996-02-13 1996-02-13 Conjugates useful in the treatment of benign prostatic hyperplasia
PCT/US1996/016490 WO1997014416A1 (en) 1995-10-18 1996-10-15 Conjugates useful in the treatment of benign prostatic hyperplasia
EP96936504A EP0855910A4 (en) 1995-10-18 1996-10-15 Conjugates useful in the treatment of benign prostatic hyperplasia
AU74321/96A AU708475B2 (en) 1995-10-18 1996-10-15 Conjugates useful in the treatment of benign prostatic hyperplasia
JP9515930A JP2000506494A (en) 1995-10-18 1996-10-15 Complexes useful for treating benign prostatic hyperplasia
CA 2234763 CA2234763A1 (en) 1995-10-18 1996-10-15 Conjugates useful in the treatment of benign prostatic hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9602903.8A GB9602903D0 (en) 1996-02-13 1996-02-13 Conjugates useful in the treatment of benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
GB9602903D0 true GB9602903D0 (en) 1996-04-10

Family

ID=10788606

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9602903.8A Pending GB9602903D0 (en) 1995-10-18 1996-02-13 Conjugates useful in the treatment of benign prostatic hyperplasia

Country Status (1)

Country Link
GB (1) GB9602903D0 (en)

Similar Documents

Publication Publication Date Title
EP0926955A4 (en) Conjugates useful in the treatment of prostate cancer
SI0968208T1 (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
IL129356A0 (en) Conjugates useful in the treatment of prostate cancer
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
PL340768A1 (en) Conjugates useful in treating prostatic carcinoma
IL132836A0 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
HK1030776A1 (en) Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
AU6570998A (en) Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
ZA991319B (en) Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
EP0748627A3 (en) Melatonin agonists for use in the treatment of benign prostatic hyperplasia
EP1140906A4 (en) Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
AU2002300904A1 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
ZA979655B (en) Conjugates useful in the treatment of prostate cancer.
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU2003204320A1 (en) Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
GB9626309D0 (en) Conjugates useful in the treatment of prostate cancer
GB9624170D0 (en) Conjugates useful in the treatment of prostate cancer
SI0942754T1 (en) Conjugates useful in the treatment of prostate cancer
GB9718160D0 (en) Conjugates useful in the treatment of prostate cancer
ZA922810B (en) New combination treatment for benign prostatic hyperplasia